Blomquist, Paula

Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern

Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.-M., et al. (2021) · New England Journal of Medicine

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 2,420

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February

Grint, D. J., Wing, K., Williamson, E., McDonald, H. I., Bhaskaran, K., Evans, D., Evans, S. J., Walker, A. J., Hickman, G., Nightingale, E., et al. (2021) · Eurosurveillance

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 189

Epidemiology of confirmed COVID-19 deaths in adults, England, March–December 2020

Brown, A. E., Heinsbroek, E., Kall, M. M., Allen, H., Beebeejaun, K., Blomquist, P., Campos-Matos, I., Campbell, C. N. J., Mohammed, H., Sinka, K., et al. (2021) · Emerging Infectious Diseases

COVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

Cited by 29